Last update: Aug. 27, 2014

Trimetazidine

High Risk probable for breastfeeding


Poorly safe.
Evaluate carefully.
Use a safer alternative.
Read the Comment.

Vasodilator drug used in the treatment of Meniere’s Syndrome. Although GI side effects are likely, because experience on breastfeeding is lacking, it would be safer to use the recommended alternative drug.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Trimetazidine is also known as


Group

Trimetazidine belongs to this group or family:

Tradenames

Main tradenames from several countries containing Trimetazidine in its composition:

Pharmacokinetics

Variable Value Unit
Bioavailability 85 %
Molecular weight 339 daltons
Protein Binding 16 %
Tmax 2 hours
T1/2 6 hours

References

We are working to add the scientific references of this product. It will be available soon. If you wish to have access to this information, please let us know by leaving your comment in the opinion section below.

Total visits

2,545

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM